Position in SIGA
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$1,008,389
-$789,105 QoQ
Shares Held
188,484
-35.9% QoQ
Ownership
0.262%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SIGA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026ACADIAN ASSET MANAGEMENT LLC holds $533,943,071 across 32 Drug Manufacturers - Specialty & Generic names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
318,320 | $172,475,325 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
441,371 | $74,388,668 | |
| 3 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
679,083 | $43,427,357 | |
| 4 | RDY |
Dr Reddys Laboratories Ltd
|
2,260,243 | $32,750,921 | |
| 5 | INDV |
Indivior Pharmaceuticals, Inc.
|
733,974 | $30,114,953 | |
| 6 | AMRX |
Amneal Pharmaceuticals, Inc.
|
1,650,255 | $28,565,914 | |
| 7 | BHC |
Bausch Health Companies Inc.
|
5,482,986 | $27,031,120 | |
| 8 | ZTS |
Zoetis Inc.
|
364,442 | $26,188,802 |
All Filings in SIGA
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,008,389 | 188,484 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $1,797,494 | 294,189 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $782,151 | 85,481 | Shares | Defined | 2025-11-13 | |
| 2021-06-30 | $140,678 | 22,401 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $95,855 | 14,747 | Shares | Defined | 2021-05-11 | |
| No filing history on record for this holder in this stock. | ||||||